![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
K Raynor, H Kong, Y Chen, K Yasuda, L Yu, GI Bell and T Reisine
Department of Pharmacology, University of Pennsylvania School of Medicine, Philadelphia 19104.
Opioid drugs, such as morphine, and the endogenous opioid peptides, namely the enkephalins, endorphins, and dynorphins, exert a wide spectrum of physiological and behavioral effects, including effects on pain perception, mood, motor control, and autonomic functions. These effects are mediated via membrane-bound receptors, of which the best characterized are the kappa, delta, and mu receptors. The existence of these distinct types of opioid receptors has recently been confirmed by molecular cloning. In the present study, we have examined the pharmacological profiles of the cloned kappa, delta, and mu receptors using a battery of widely employed opioid agents. Our results suggest that the cloned kappa and mu receptors have pharmacological characteristics similar to those of the endogenously expressed kappa 1 and mu receptors, respectively. The cloned delta receptor displays a pharmacological profile consistent with that of a delta 2 receptor. Opioid agents with abuse potential possess high affinities for the mu receptor. The availability of the cloned receptors will facilitate the identification and development of more specific and selective compounds with greater therapeutic potential and fewer undesirable side effects.
This article has been cited by other articles:
|
|
 |
|
  G. Henriksen and F. Willoch Imaging of opioid receptors in the central nervous system Brain, May 1, 2008; 131(5): 1171 - 1196. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Boecker, T. Sprenger, M. E. Spilker, G. Henriksen, M. Koppenhoefer, K. J. Wagner, M. Valet, A. Berthele, and T. R. Tolle The Runner's High: Opioidergic Mechanisms in the Human Brain Cereb Cortex, February 21, 2008; (2008) bhn013v1. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. P. Ford, M. J. Beckstead, and J. T. Williams Kappa Opioid Inhibition of Somatodendritic Dopamine Inhibitory Postsynaptic Currents J Neurophysiol, January 1, 2007; 97(1): 883 - 891. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. N. Wenk, J.-D. Brederson, and C. N. Honda Morphine Directly Inhibits Nociceptors in Inflamed Skin J Neurophysiol, April 1, 2006; 95(4): 2083 - 2097. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. S. Talbot, R. Narendran, E. R. Butelman, Y. Huang, K. Ngo, M. Slifstein, D. Martinez, M. Laruelle, and D.-R. Hwang 11C-GR103545, a Radiotracer for Imaging{kappa}-Opioid Receptors In Vivo with PET: Synthesis and Evaluation in Baboons J. Nucl. Med., March 1, 2005; 46(3): 484 - 494. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. K. Melichar, S. P. Hume, T. M. Williams, M. R. C. Daglish, L. G. Taylor, R. Ahmad, A. L. Malizia, D. J. Brooks, J. S. Myles, A. Lingford-Hughes, et al. Using [11C]Diprenorphine to Image Opioid Receptor Occupancy by Methadone in Opioid Addiction: Clinical and Preclinical Studies J. Pharmacol. Exp. Ther., January 1, 2005; 312(1): 309 - 315. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. J. Valenzano, W. Miller, Z. Chen, S. Shan, G. Crumley, S. F. Victory, E. Davies, J.-C. Huang, N. Allie, S. J. Nolan, et al. DiPOA ([8-(3,3-Diphenyl-propyl)-4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]dec-3-yl]-acetic Acid), a Novel, Systemically Available, and Peripherally Restricted Mu Opioid Agonist with Antihyperalgesic Activity: I. In Vitro Pharmacological Characterization and Pharmacokinetic Properties J. Pharmacol. Exp. Ther., August 1, 2004; 310(2): 783 - 792. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. I. Boyadjieva, K. Chaturvedi, M. M. Poplawski, and D. K. Sarkar Opioid Antagonist Naltrexone Disrupts Feedback Interaction between {micro} and {delta} Opioid Receptors in Splenocytes to Prevent Alcohol Inhibition of NK Cell Function J. Immunol., July 1, 2004; 173(1): 42 - 49. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. L. Goodman, L. M. Coolen, G. M. Anderson, S. L. Hardy, M. Valent, J. M. Connors, M. E. Fitzgerald, and M. N. Lehman Evidence That Dynorphin Plays a Major Role in Mediating Progesterone Negative Feedback on Gonadotropin-Releasing Hormone Neurons in Sheep Endocrinology, June 1, 2004; 145(6): 2959 - 2967. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. D. Sullivan and S. M. Moenter {gamma}-Aminobutyric Acid Neurons Integrate and Rapidly Transmit Permissive and Inhibitory Metabolic Cues to Gonadotropin-Releasing Hormone Neurons Endocrinology, March 1, 2004; 145(3): 1194 - 1202. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. A. Khasabova, C. Harding-Rose, D. A. Simone, and V. S. Seybold Differential Effects of CB1 and Opioid Agonists on Two Populations of Adult Rat Dorsal Root Ganglion Neurons J. Neurosci., February 18, 2004; 24(7): 1744 - 1753. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Shaqura, C. Zollner, S. A. Mousa, C. Stein, and M. Schafer Characterization of {micro} Opioid Receptor Binding and G Protein Coupling in Rat Hypothalamus, Spinal Cord, and Primary Afferent Neurons during Inflammatory Pain J. Pharmacol. Exp. Ther., February 1, 2004; 308(2): 712 - 718. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Ott, R. Frischknecht, and A. Pluckthun Construction and characterization of a kappa opioid receptor devoid of all free cysteines Protein Eng. Des. Sel., January 1, 2004; 17(1): 37 - 48. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Townsend IV, P. S. Portoghese, and D. R. Brown Characterization of Specific Opioid Binding Sites in Neural Membranes from the Myenteric Plexus of Porcine Small Intestine J. Pharmacol. Exp. Ther., January 1, 2004; 308(1): 385 - 393. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Pil and J. Tytgat Serine 329 of the {micro}-Opioid Receptor Interacts Differently with Agonists J. Pharmacol. Exp. Ther., March 1, 2003; 304(3): 924 - 930. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. C. Silbert, D. W. Beacham, and E. W. McCleskey Quantitative Single-Cell Differences in {micro}-Opioid Receptor mRNA Distinguish Myelinated and Unmyelinated Nociceptors J. Neurosci., January 1, 2003; 23(1): 34 - 42. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. M. Silva, H. C. Grossman, M. M. Hadjimarkou, G. C. Rossi, G. W. Pasternak, and R. J. Bodnar Dynorphin A1-17-Induced Feeding: Pharmacological Characterization Using Selective Opioid Antagonists and Antisense Probes in Rats J. Pharmacol. Exp. Ther., May 1, 2002; 301(2): 513 - 518. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. C. Newman, S. S. Sands, D. R. Wallace, and C. W. Stevens Characterization of {micro}, kappa , and delta Opioid Binding in Amphibian Whole Brain Tissue Homogenates J. Pharmacol. Exp. Ther., April 1, 2002; 301(1): 364 - 370. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Townsend IV and D. R. Brown Predominance of delta -Opioid-Binding Sites in the Porcine Enteric Nervous System J. Pharmacol. Exp. Ther., March 1, 2002; 300(3): 900 - 909. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Meis, T. Munsch, and H.-C. Pape Antioscillatory Effects of Nociceptin/Orphanin FQ in Synaptic Networks of the Rat Thalamus J. Neurosci., February 1, 2002; 22(3): 718 - 727. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. J. McFadyen, T. G. Metzger, M.G. Paterlini, and D. M. Ferguson Exploring the unique pharmacology of a novel opioid receptor, ZFOR1, using molecular modeling and the `message-address' concept Protein Eng. Des. Sel., December 1, 2001; 14(12): 953 - 960. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. R. Butelman, M. C. H. Ko, J. R. Traynor, J. A. Vivian, M.-J. Kreek, and J. H. Woods GR89,696: A Potent kappa -Opioid Agonist with Subtype Selectivity in Rhesus Monkeys J. Pharmacol. Exp. Ther., September 1, 2001; 298(3): 1049 - 1059. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Gaveriaux-Ruff, D. Filliol, F. Simonin, H. W. D. Matthes, and B. L. Kieffer Immunosuppression by delta -Opioid Antagonist Naltrindole: delta - and Triple {micro}/delta /kappa -Opioid Receptor Knockout Mice Reveal a Nonopioid Activity J. Pharmacol. Exp. Ther., September 1, 2001; 298(3): 1193 - 1198. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. H. Szeto, Y. Soong, D. Wu, and J. Fasolo Resensitization of Blood Pressure Response to {micro}-Opioid Peptide Agonists After Acute Desensitization Anesth. Analg., September 1, 2001; 93(3): 581 - 586. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Sternini Receptors and Transmission in the Brain-Gut Axis: Potential for Novel Therapies: III. {micro}-Opioid receptors in the enteric nervous system Am J Physiol Gastrointest Liver Physiol, July 1, 2001; 281(1): G8 - G15. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Mehta, G. Bot, T. Reisine, and M.-F. Chesselet Endomorphin-1: Induction of Motor Behavior and Lack of Receptor Desensitization J. Neurosci., June 15, 2001; 21(12): 4436 - 4442. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. A. Martin and P. L. Prather Interaction of Co-Expressed {micro}- and {delta}-Opioid Receptors in Transfected Rat Pituitary GH3 Cells Mol. Pharmacol., April 1, 2001; 59(4): 774 - 783. [Abstract] [Full Text]
|
|
|
|
 |
|
 J. T. Williams, M. J. Christie, and O. Manzoni Cellular and Synaptic Adaptations Mediating Opioid Dependence Physiol Rev, January 1, 2001; 81(1): 299 - 343. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. L. Prather, L. Song, E. T. Piros, P. Y. Law, and T. G. Hales delta -Opioid Receptors Are More Efficiently Coupled to Adenylyl Cyclase Than to L-Type Ca2+ Channels in Transfected Rat Pituitary Cells J. Pharmacol. Exp. Ther., November 1, 2000; 295(2): 552 - 562. [Abstract] [Full Text]
|
|
|
|
|
|
P. H. Tso and Y. H. Wong Gz Can Mediate the Acute Actions of {micro}- and kappa -Opioids but Is Not Involved in Opioid-Induced Adenylyl Cyclase Supersensitization J. Pharmacol. Exp. Ther., October 1, 2000; 295(1): 168 - 176. [Abstract] [Full Text]
|
|
|
|
|
|
C. Ulens, M. Van Boven, P. Daenens, and J. Tytgat Interaction of p-Fluorofentanyl on Cloned Human Opioid Receptors and Exploration of the Role of Trp-318 and His-319 in {micro}-Opioid Receptor Selectivity J. Pharmacol. Exp. Ther., September 1, 2000; 294(3): 1024 - 1033. [Abstract] [Full Text]
|
|
|
|
|
|
M. Ogura and H. Kita Dynorphin Exerts Both Postsynaptic and Presynaptic Effects in the Globus Pallidus of the Rat J Neurophysiol, June 1, 2000; 83(6): 3366 - 3376. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. B. Deng, W. Guang, and J. B. Wang Selected Cysteine Residues in Transmembrane Domains of {micro}-Opioid Receptor Are Critical for Effects of Sulfhydryl Reagents J. Pharmacol. Exp. Ther., April 1, 2000; 293(1): 113 - 120. [Abstract] [Full Text]
|
|
|
|
|
|
P. A. Zaki, D. E. Keith Jr., G. A. Brine, F. I. Carroll, and C. J. Evans Ligand-Induced Changes in Surface {micro}-Opioid Receptor Number: Relationship to G Protein Activation? J. Pharmacol. Exp. Ther., March 1, 2000; 292(3): 1127 - 1134. [Abstract] [Full Text]
|
|
|
|
 |
|
 P. E. Benedict, M. B. Benedict, T.-P. Su, and S. F. Bolling Opiate Drugs and {delta}-Receptor-Mediated Myocardial Protection Circulation, November 9, 1999; 100(90002): II-357 - 360. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. H. Yoon, T.-M. Lo, H. H. Loh, and S. A. Thayer delta -Opioid-Induced Liberation of Gbeta gamma Mobilizes Ca2+ Stores in NG108-15 Cells Mol. Pharmacol., November 1, 1999; 56(5): 902 - 908. [Abstract] [Full Text]
|
|
|
|
|
|
C. G. Acosta and H. S. Lopez delta Opioid Receptor Modulation of Several Voltage-Dependent Ca2+ Currents in Rat Sensory Neurons J. Neurosci., October 1, 1999; 19(19): 8337 - 8348. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. M. Quock, T. H. Burkey, E. Varga, Y. Hosohata, K. Hosohata, S. M. Cowell, C. A. Slate, F. J. Ehlert, W. R. Roeske, and H. I. Yamamura The delta -Opioid Receptor: Molecular Pharmacology, Signal Transduction, and the Determination of Drug Efficacy Pharmacol. Rev., September 1, 1999; 51(3): 503 - 532. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. L. Whistler and M. von Zastrow Dissociation of Functional Roles of Dynamin in Receptor-mediated Endocytosis and Mitogenic Signal Transduction J. Biol. Chem., August 27, 1999; 274(35): 24575 - 24578. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. R. Butelman, T. J. Harris, A. Perez, and M.-J. Kreek Effects of Systemically Administered Dynorphin A(1-17) in Rhesus Monkeys J. Pharmacol. Exp. Ther., August 1, 1999; 290(2): 678 - 686. [Abstract] [Full Text]
|
|
|
|
|
|
H. Machelska, M. Pflüger, W. Weber, M. Piranvisseh-Völk, J. D. Daubert, R. DeHaven, and C. Stein Peripheral Effects of the kappa -Opioid Agonist EMD 61753 on Pain and Inflammation in Rats and Humans J. Pharmacol. Exp. Ther., July 1, 1999; 290(1): 354 - 361. [Abstract] [Full Text]
|
|
|
|
|
|
D. L. DeHaven-Hudkins, L. C. Burgos, J. A. Cassel, J. D. Daubert, R. N. DeHaven, E. Mansson, H. Nagasaka, G. Yu, and T. Yaksh Loperamide (ADL 2-1294), an Opioid Antihyperalgesic Agent with Peripheral Selectivity J. Pharmacol. Exp. Ther., April 1, 1999; 289(1): 494 - 502. [Abstract] [Full Text]
|
|
|
|
 |
|
 R. H. Schwartz Adolescent Heroin Use: A Review Pediatrics, December 1, 1998; 102(6): 1461 - 1466. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Meis and H.-C. Pape Postsynaptic Mechanisms Underlying Responsiveness of Amygdaloid Neurons to Nociceptin/Orphanin FQ J. Neurosci., October 15, 1998; 18(20): 8133 - 8144. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. C. Froehlich, N. E. Badia-Elder, R. W. Zink, D. E. McCullough, and P. S. Portoghese Contribution of the Opioid System to Alcohol Aversion and Alcohol Drinking Behavior J. Pharmacol. Exp. Ther., October 1, 1998; 287(1): 284 - 292. [Abstract] [Full Text]
|
|
|
|
|
|
H. W. D. Matthes, C. Smadja, O. Valverde, J.-L. Vonesch, A. S. Foutz, E. Boudinot, M. Denavit-Saubie, C. Severini, L. Negri, B. P. Roques, et al. Activity of the delta -Opioid Receptor Is Partially Reduced, Whereas Activity of the kappa -Receptor Is Maintained in Mice Lacking the µ-Receptor J. Neurosci., September 15, 1998; 18(18): 7285 - 7295. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Bot, A. D. Blake, S. Li, and T. Reisine Fentanyl and its Analogs Desensitize the Cloned Mu Opioid Receptor J. Pharmacol. Exp. Ther., June 1, 1998; 285(3): 1207 - 1218. [Abstract] [Full Text]
|
|
|
|
|
|
M. F. Olive and N. T. Maidment Opioid Regulation of Pallidal Enkephalin Release: Bimodal Effects of Locally Administered Mu and Delta Opioid Agonists in Freely Moving Rats J. Pharmacol. Exp. Ther., June 1, 1998; 285(3): 1310 - 1316. [Abstract] [Full Text]
|
|
|
|
 |
|
 C. Gaveriaux-Ruff, H. W. D. Matthes, J. Peluso, and B. L. Kieffer Abolition of morphine-immunosuppression in mice lacking the µ-opioid receptor gene PNAS, May 26, 1998; 95(11): 6326 - 6330. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. R. Butelman, M.-C. Ko, K. Sobczyk-Kojiro, H. I. Mosberg, B. V. Bemmel, G. Zernig, and J. H. Woods Kappa-Opioid Receptor Binding Populations in Rhesus Monkey Brain: Relationship to an Assay of Thermal Antinociception J. Pharmacol. Exp. Ther., May 1, 1998; 285(2): 595 - 601. [Abstract] [Full Text]
|
|
|
|
|
|
G. Bot, A. D. Blake, S. Li, and T. Reisine Mutagenesis of the Mouse Delta Opioid Receptor Converts (-)-Buprenorphine from a Partial Agonist to an Antagonist J. Pharmacol. Exp. Ther., January 1, 1998; 284(1): 283 - 290. [Abstract] [Full Text]
|
|
|
|
|
|
M. J. Clark, P. J. Emmerson, A. Mansour, H. Akil, J. H. Woods, P. S. Portoghese, A. E. Remmers, and F. Medzihradsky Opioid Efficacy in a C6 Glioma Cell Line Stably Expressing the Delta Opioid Receptor J. Pharmacol. Exp. Ther., November 1, 1997; 283(2): 501 - 510. [Abstract] [Full Text]
|
|
|
|
|
|
J. K. Staley, R. B. Rothman, K. C. Rice, J. Partilla, and D. C. Mash kappa 2 Opioid Receptors in Limbic Areas of the Human Brain Are Upregulated by Cocaine in Fatal Overdose Victims J. Neurosci., November 1, 1997; 17(21): 8225 - 8233. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Chu, S. Murray, D. Lissin, and M. von Zastrow delta and kappa Opioid Receptors Are Differentially Regulated by Dynamin-dependent Endocytosis When Activated by the Same Alkaloid Agonist J. Biol. Chem., October 24, 1997; 272(43): 27124 - 27130. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. P. O'Brien A Range of Research-Based Pharmacotherapies for Addiction Science, October 3, 1997; 278(5335): 66 - 70. [Abstract] [Full Text]
|
|
|
|
|
|
M. F. Olive, B. Anton, P. Micevych, C. J. Evans, and N. T. Maidment Presynaptic Versus Postsynaptic Localization of µ and delta Opioid Receptors in Dorsal and Ventral Striatopallidal Pathways J. Neurosci., October 1, 1997; 17(19): 7471 - 7479. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Bot, A. D. Blake, S. Li, and T. Reisine Opioid Regulation of the Mouse delta -Opioid Receptor Expressed in Human Embryonic Kidney 293 Cells Mol. Pharmacol., August 1, 1997; 52(2): 272 - 281. [Abstract] [Full Text]
|
|
|
|
|
|
S. Chakrabarti, W. Yang, P.-Y. Law, and H. H. Loh The µ-Opioid Receptor Down-Regulates Differently from the delta -Opioid Receptor: Requirement of a High Affinity Receptor/G Protein Complex Formation Mol. Pharmacol., July 1, 1997; 52(1): 105 - 113. [Abstract] [Full Text]
|
|
|
|
|
|
S. F. Law and T. Reisine J. Pharmacol. Exp. Ther., June 1, 1997; 281(3): 1476 - 1486. [Abstract]
|
|
|
|
 |
|
 M. Tian, H. E. Broxmeyer, Y. Fan, Z. Lai, S. Zhang, S. Aronica, S. Cooper, R. M. Bigsby, R. Steinmetz, S. J. Engle, et al. Altered Hematopoiesis, Behavior, and Sexual Function in µ Opioid Receptor-deficient Mice J. Exp. Med., April 21, 1997; 185(8): 1517 - 1522. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. J. Chen, J. Dymshitz, and M. R. Vasko Regulation of Opioid Receptors in Rat Sensory Neurons in Culture Mol. Pharmacol., April 1, 1997; 51(4): 666 - 673. [Abstract] [Full Text]
|
|
|
|
|
|
AllanD. Blake, G. Bot, JohnC. Freeman, and T. Reisine Differential Opioid Agonist Regulation of the MouseµOpioid Receptor J. Biol. Chem., January 10, 1997; 272(2): 782 - 790. [Abstract] [Full Text] |
